U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07068555) titled 'Prostate Cancer Vaccines' on July 06.
Brief Summary: Tumor antigens are protein fragments produced by cancer cells carrying genetic mutations, and many are similar to normal protein antigens, making them unrecognizable by the immune system. Many tumor vaccines are based on a single tumor antigen. This study is based on multiple target antigens using tumor lysates or synthetic peptides. The immune modulation by dendritic-cell- (DC)based cancer vaccines consists of genetically modified dendritic cells to prime and activate T cells to target cancer cells. The study is based on an advanced cancer vaccine technology, which aims to evalua...